To determine whether the PCA3 and MALAT1 scores were correlated with the tumor grade of PCa, we evaluated the PCA3 and MALAT1 scores in the clinically significant PCa (GS ≥ 7) with those in nonaggressive disease (PCa with GS6 and benign disease). Here, MALAT1 is linked to posterior cortical atrophy.